Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

December 2011 - FRMC

Association of QRS Duration and Reduction in Clinical Events with CRT
12/14/2011
In 2010 in the United States, costs related to heart failure were >$39 billion; heart failure affects approximately 6 million people in the United States and an additional 6.5 million in Europe. Cardiac resynchronization therapy (CRT)...
In 2010 in the United States, costs related to heart failure were >$39 billion; heart failure affects approximately 6 million people in the United States and an additional 6.5 million in Europe. Cardiac resynchronization therapy (CRT)...
In 2010 in the United States,...
12/14/2011
First Report Managed Care
Enrollment Update on the Medicare Advantage Market
12/14/2011
Despite provisions in the Patient Protection and Affordable Care Act (ACA) of 2010 that froze Medicare Advantage (MA) payment rates to 2010 levels, enrollment in MA plans continued to rise in 2011. Likewise, with the use of private...
Despite provisions in the Patient Protection and Affordable Care Act (ACA) of 2010 that froze Medicare Advantage (MA) payment rates to 2010 levels, enrollment in MA plans continued to rise in 2011. Likewise, with the use of private...
Despite provisions in the...
12/14/2011
First Report Managed Care
Preventing Exacerbations of COPD with Azithromycin
12/14/2011
A substantial proportion of the cost of treating patients with chronic obstructive pulmonary disease (COPD) can be attributed to acute exacerbations requiring visits to physicians’ offices and emergency departments as well as days lost from...
A substantial proportion of the cost of treating patients with chronic obstructive pulmonary disease (COPD) can be attributed to acute exacerbations requiring visits to physicians’ offices and emergency departments as well as days lost from...
A substantial proportion of the...
12/14/2011
First Report Managed Care
Patient’s Life Expectancy and the Need for Fecal Occult Blood Testing
12/14/2011
Just as follow-up colonoscopy is targeted to healthier older adults, a targeted approach for Fecal Occult Blood Test screening may increase life expectancy. 
Just as follow-up colonoscopy is targeted to healthier older adults, a targeted approach for Fecal Occult Blood Test screening may increase life expectancy. 
Just as follow-up colonoscopy is...
12/14/2011
First Report Managed Care
Healthcare Reform Poll Returns to Split Opinions
12/14/2011
The November 2011 tracking poll conducted by the Henry J. Kaiser Family Foundation found the public in a negative mood about healthcare reform and its perceived impacts. For the 19 months between the March 2010 signing of the Patient...
The November 2011 tracking poll conducted by the Henry J. Kaiser Family Foundation found the public in a negative mood about healthcare reform and its perceived impacts. For the 19 months between the March 2010 signing of the Patient...
The November 2011 tracking poll...
12/14/2011
First Report Managed Care
Despite Being Overlooked, Glaucoma Is Serious and Costly
12/14/2011
Las Vegas—Approximately 60 million people worldwide have glaucoma, a group of eye diseases that are the leading cause of blindness. In the United States, annual glaucoma expenditures are >$2.5 billion, with additional costs for falls,...
Las Vegas—Approximately 60 million people worldwide have glaucoma, a group of eye diseases that are the leading cause of blindness. In the United States, annual glaucoma expenditures are >$2.5 billion, with additional costs for falls,...
Las Vegas—Approximately 60...
12/14/2011
First Report Managed Care
Type 2 Diabetes Treatment Options Increasing
12/14/2011
Las Vegas—Until the past decade, patients with type 2 diabetes had few treatment options. They were limited to animal insulin, sulfonylurea, or metformin. The US Food and Drug Administration (FDA) approved metformin in 1994; it is used in...
Las Vegas—Until the past decade, patients with type 2 diabetes had few treatment options. They were limited to animal insulin, sulfonylurea, or metformin. The US Food and Drug Administration (FDA) approved metformin in 1994; it is used in...
Las Vegas—Until the past decade,...
12/14/2011
First Report Managed Care
Physician Practice Acquisitions Growing
12/14/2011
Las Vegas—With the costs of private practices growing and reimbursement rates decreasing, more physicians are now employed by hospitals, which are acquiring practices to adjust to a changing healthcare landscape. Still, the strategy is filled...
Las Vegas—With the costs of private practices growing and reimbursement rates decreasing, more physicians are now employed by hospitals, which are acquiring practices to adjust to a changing healthcare landscape. Still, the strategy is filled...
Las Vegas—With the costs of...
12/14/2011
First Report Managed Care
Hepatitis C Therapy Options Expanding
12/14/2011
Las Vegas—Throughout the world, 200 million people have been infected with the hepatitis C virus, including 4.1 million in the United States. Until recently, though, patients had few treatment options.
Las Vegas—Throughout the world, 200 million people have been infected with the hepatitis C virus, including 4.1 million in the United States. Until recently, though, patients had few treatment options.
Las Vegas—Throughout the world,...
12/14/2011
First Report Managed Care

News

News
New Therapies to Treat Multiple Sclerosis
12/14/2011
Las Vegas—Patients with multiple sclerosis (MS) often suffer from relapses, creating a situation in which their disease progresses and disability worsens. The deteriorating condition also contributes to increased healthcare costs.
Las Vegas—Patients with multiple sclerosis (MS) often suffer from relapses, creating a situation in which their disease progresses and disability worsens. The deteriorating condition also contributes to increased healthcare costs.
Las Vegas—Patients with multiple...
12/14/2011
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Ramucirumab Improves Overall Survival in Patients with Non-Small Cell Lung Cancer
05/31/2014
Chicago—Patients with advanced, progressive non-small cell lung cancer (NSCLC) who received ramucirumab plus docetaxel had a significant improvement in overall survival and progression-free survival compared with a group taking docetaxel and...
Chicago—Patients with advanced, progressive non-small cell lung cancer (NSCLC) who received ramucirumab plus docetaxel had a significant improvement in overall survival and progression-free survival compared with a group taking docetaxel and...
Chicago—Patients with advanced,...
05/31/2014
First Report Managed Care
News
PCCN Becomes First Pediatric Network to Receive URAC Clinical Integration Accreditation
04/21/2017
Phoenix Children’s Care Network received accreditation from URAC for their clinical integration programs.
Phoenix Children’s Care Network received accreditation from URAC for their clinical integration programs.
Phoenix Children’s Care...
04/21/2017
First Report Managed Care
News
Improving Intervention Effectiveness for Eczema Treatment Among Older Adults
09/08/2021
“There appears to be a considerable burden of eczema among older persons in the community,” researchers wrote. “A community-based approach involving non-governmental organizations has the potential to identify cases and offer care close to...
“There appears to be a considerable burden of eczema among older persons in the community,” researchers wrote. “A community-based approach involving non-governmental organizations has the potential to identify cases and offer care close to...
“There appears to be a...
09/08/2021
First Report Managed Care
Duration of Treatment with Linaclotide
07/22/2013
Patients with irritable bowel syndrome whose symptoms improved after 4 weeks of treatment with linaclotide were highly likely to continue feeling better at week 12.
Patients with irritable bowel syndrome whose symptoms improved after 4 weeks of treatment with linaclotide were highly likely to continue feeling better at week 12.
Patients with irritable bowel...
07/22/2013
First Report Managed Care
News
Takeda`s Actos Drug Suspended in France on Cancer Risk Study
06/10/2011
06/10/2011
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

December 2011 Volume 8 Issue 12

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement